XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash Flows From Operating Activities:              
Net loss $ (12,585) $ (25,120) $ (23,420) $ (35,731) $ (58,045) $ (92,441)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation 200   200   653 493  
Amortization of intangible assets 200   100   720 300  
Amortization of debt-related costs         437 344  
Stock-based compensation         27,406 20,415  
Loss on debt extinguishment 0   0   0 1,944 $ 1,900
Non-cash lease expense         528 462  
Net amortization/accretion of marketable securities         (4,557) (2,732)  
Realized loss on equity investments         0 591  
Change in fair value of equity warrants issued by licensee         0 201  
Unrealized (gain) loss from transactions denominated in a foreign currency         14 7  
Changes in operating assets and liabilities:              
Accounts receivable, net         (25,860) (12,538)  
Inventory         (1,215) (2,273)  
Other receivables         (418) (52)  
Prepaid expenses         (6,471) 683  
Other non-current assets         (146) 614  
Accounts payable and other accrued liabilities         37,445 25,290  
Accrued payroll and benefits         (2,272) (1,920)  
Other long-term liabilities         0 (233)  
Net cash used in operating activities         (31,781) (60,845)  
Cash Flows From Investing Activities:              
Proceeds from maturities of marketable securities         269,718 37,535  
Purchases of marketable securities         (357,606) (172,661)  
Purchases of long-term investments         0 (3,000)  
Purchases of property and equipment         (3,501) (1,495)  
Net cash used in investing activities         (91,389) (139,621)  
Cash Flows From Financing Activities:              
Proceeds from issuance of common stock, net of paid issuance costs         134,771 98,287  
Proceeds from issuance of pre-funded warrants, net of paid issuance costs         0 9,365  
Proceeds from sale of common stock under employee stock purchase plan         1,101 1,136  
Proceeds from exercise of stock options         5,204 3,341  
Proceeds from long-term debt         0 75,000  
Payments for debt extinguishment         0 (31,877)  
Payments of debt issuance costs         0 (3,523)  
Net cash provided by financing activities         141,076 151,729  
Net increase (decrease) in cash, cash equivalents and restricted cash         17,906 (48,737)  
Cash, cash equivalents and restricted cash at beginning of period   $ 97,381   $ 224,947 97,381 224,947 224,947
Cash, cash equivalents and restricted cash at end of period $ 115,287   $ 176,210   115,287 176,210 $ 97,381
Supplemental Disclosures From Noncash, Investing and Financing Activities:              
Operating lease right-of-use asset obtained in exchange for operating lease liability         10,209 384  
Interest expense paid in cash         6,284 5,488  
Additions of intangible assets included within accounts payable and other accrued liabilities         0 5,000  
Additions of property and equipment included within accounts payable and other accrued liabilities         1,499 58  
Offering costs included within accounts payable and other accrued liabilities         $ 0 $ 18